Recombinant Human RNase H1/RNH1 protein (GST tag N-Terminus)
5
(1 Review)
|
(6 Publications)
Recombinant Human RNase H1/RNH1 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 286 aa range, expressed in Wheat germ, with >80%, suitable for SDS-PAGE, ELISA, WB.
대체 명칭 보기
RNH1, RNASEH1, Ribonuclease H1, RNase H1, Ribonuclease H type II
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human RNase H1/RNH1 protein (GST tag N-Terminus) (AB153634)
ab153634 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity 정보
제품 세부 정보
Protein concentration is above or equal to 0.03 mg/ml.
This product was previously labelled as RNase H1
서열 정보
특성 및 보관 정보
제형
Purification 테크닉
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
일반 정보
기능
Endonuclease that specifically degrades the RNA of RNA-DNA hybrids (PubMed : 10497183). Plays a role in RNA polymerase II (RNAp II) transcription termination by degrading R-loop RNA-DNA hybrid formation at G-rich pause sites located downstream of the poly(A) site and behind the elongating RNAp II (PubMed : 21700224).
서열 유사성
Belongs to the RNase H family.
타겟 정보
제품이 사용된 논문 (6)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Molecular therapy. Nucleic acids 36:102404 PubMed39759873
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109797 PubMed38993671
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:8021 PubMed38049398
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:2413 PubMed37105964
2023
Applications
Unspecified application
Species
Unspecified reactive species
Organic & biomolecular chemistry 20:8243-8258 PubMed36222332
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:1654 PubMed33712600
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com